Search

Developing the biotechnology industry relies on advances in scientific knowledge and its commercial exploitation. Recent efforts to develop biotechnology businesses yielded mixed results, due to the gulf between science and business sensibilities. Turning good science into commercially valuable biotechnology products requires specialized skills, knowledge, effective communication, and imagination. Scientific motives and convictions clash with less precise and risky research commercialisation imperatives. Marketplace realities are driven by a number of human, cultural, and political factors that fall within the domain of business of biotechnology. This paper explores the organisational dynamics of developing medical biotechnology businesses and argues that the successful development of biotechnology industry requires effective organisational structures and the coevolution of two types of knowledge systems - scientific and innovative- for continuous growth of biotechnology firms. [ABSTRACT FROM AUTHOR]

Biotechnology, the surging wave of economic development in the world, prompted Newly Industrialised Economies (NIEs) in Asia to emulate developed countries in biotechnology development. The stakes are however high and the uncertainty about return on investment has provoked a careful assessment of national scientific and technological strengths. With a focus on Hong Kong, Singapore, and Taiwan, this paper reviews the current market conditions and key factors that may advantage the development of biotechnology industry in the NIEs. It is argued that co-evolution of scientific and technology capabilities are essential, and the NIEs will have to leverage their comparative advantages in technological capabilities and should focus on core competencies in the already locally established biotechnology areas. [ABSTRACT FROM AUTHOR]

Introduces a series of articles on the challenges of commercialization of biotechnology.

Focuses on the management of sponsored research rewards to industry and universities in the U.S. Commercialization of research outcomes; Details on the Bayh Dole Act of 1980; Reward models for managing sponsored research.

Focuses on a study which addressed the concept of research management as the generation of intellectual capital. Examination of research management practices employed by biotechnology and pharmaceutical research groups in industries and universities; Features of the generation models for research and development; Outline of the fourth generation R&D management model; Research management tools; Conclusions.

Focuses on a study which assessed the technology development needs of small and medium enterprises (SME) in Japan. Information on the progress of industrial technology in Japan; Methodology and approach; Results on industrial technological trends and methodologies in acquiring know-how and information for research and development within SME; Conclusion.

Discusses differing views of how intellectual property should be treated and how such decisions effect commercial development in center activities. Intellectual property management issues in collaborative research arrangements; Organizational management strategies for intellectual property in Australian Cooperative Research Centres; Process of negotiation and disclosure.

Editorial. Discusses the management of research collaboration and related innovation issues. Management of research and development activities; Evolution towards a knowledge-based economy; Focus on managing the exploitation of multiple sources of knowledge and its appropriate adaptation.